Ignite Creation Date:
2024-05-06 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05241093
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2022-01-16
Brief Title:
A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia AML
Sponsor:
Organization:
Tarapeutics Science Inc